Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials-Reference-Cited by-同舟云学术

Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

Published:2023-06-21 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Draelos Zoe D.¹^ORCID,Tanghetti Emil A.²,Kircik Leon H.³⁴⁵,Bhatia Neal⁶,Zeichner Joshua A.³,Sugarman Jeffrey L.⁷,Stein Gold Linda⁸

Affiliation:

1. Dermatology Consulting Services, PLLC, High Point, NC, United States

2. Center for Dermatology and Laser Surgery, Sacramento, CA, United States

3. Icahn School of Medicine at Mount Sinai, New York, NY, United States

4. Indiana University Medical Center, Indianapolis, IN, United States

5. Physicians Skin Care, PLLC, DermResearch, PLLC, and Skin Sciences, PLLC, Louisville, KY, United States

6. Therapeutics Clinical Research, San Diego, CA, United States

7. University of California, San Francisco, CA, United States

8. Henry Ford Hospital, Detroit, MI, United States

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2220446

Reference40 articles.

1. Guidelines of care for the management of acne vulgaris

2. Adult acne versus adolescent acne: a retrospective study of 1,167 patients;Skroza N;J Clin Aesthet Dermatol,2018

3. Pathogenesis and Pathogenesis Related Treatment of Acne

4. Acne vulgaris

5. Contact dermatitis to topical acne drugs: a review of the literature

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on Topical Dyad and Triple Combination Therapies Approved for Acne Vulgaris;Cureus;2024-05-31